Experts discussed guidelines from the American College of Chest Physicians and the European Respiratory Society at the 2026 CHEST meeting in Phoenix earlier this week.
|Podcasts|October 28, 2020
Meet the Board: Don Hall of DeltaSigma Talks Effects COVID has on Fee-for-Service, Value-Based Care, Health Disparities and More
Author(s)Briana Contreras
In this episode of Tuning Into the C-Suite, listeners are tuning into our next feature of the Meet the Board series where MHE's Senior Editor, Peter Wehrwein, and Associate Editor, Briana Contreras, speak with Managed Healthcare Executive Editorial Advisory Board Member, Don Hall, who is principal of DeltaSigma LLC. DeltaSigma is a consulting practice specializing in strategic problem solving for managed care organizations. In addition to being a loyal member of our board since 2007, Don most recently served as president and CEO of a nonprofit, provider-sponsored health plan. In this conversation, you’ll learn a bit about Don, personally, such as what he's currently reading, and his thoughts about the current issues healthcare is facing today.
Advertisement
To listen to more episodes featured on Tuning Into The C-Suite, visit us on Spotify , Apple Podcasts and iHeartRadio .
Advertisement
Related to this article
Melody Chang, R.Ph., says payers cover bispecific and CAR-T drugs but not the monitoring that lets community practices deliver them safely at lower cost.
Continuous glucose monitoring cut mean A1C from 8.8% to 7.2% over 26 weeks in adults with type 2 diabetes not on insulin, 0.9 points more than routine care in the CONNECT trial.
American Oncology Network’s Melody Chang, R.Ph., says 18% of its first 70 outpatient bispecific patients had CRS, all low grade with no hospitalizations.
A screening program in eight countries found early-stage type 1 diabetes in about 1 in 350 children with no family history of the disease.
Healthcare leaders should be preparing now for important changes in prior authorization and other areas of healthcare.
UC Davis Health’s Tiffany Phung, Pharm.D., and Tim Cutler, Pharm.D., say staff-driven ideas protect research independence in industry partnerships.
UC Davis Health’s Tiffany Phung, Pharm.D., and Tim Cutler, Pharm.D., say research justifies services and opens doors to limited distribution drugs.
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Apothecary Pharma recalls compounded tirzepatide and NAD+ vials over sterility concerns
2
Jessica Castle, M.D., discusses CGM’s A1C impact in non-insulin type 2 diabetes
3
Rex Hoffman, M.D., on how a CMO balances competing priorities | HSES 2026
4
Now is the time to get ready for 2027 changes in prior authorization, MA Star Ratings and others in federal healthcare law and regulations
5